Viewing StudyNCT00396227



Ignite Creation Date: 2024-05-05 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00396227
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2006-11-02

Brief Title: Safety and Efficacy of Vildagliptin vs Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CLAF237A23119
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: External Affairs
Old Organization: Novartis Pharmaceuticals

Collaborators